These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7001832)

  • 1. Insulin secretory reserve in insulin dependent patients at time of diagnosis and the first 180 days of insulin treatment.
    Madsbad S; Krarup T; Regeur L; Faber OK; Binder C
    Acta Endocrinol (Copenh); 1980 Nov; 95(3):359-63. PubMed ID: 7001832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-peptide response to glucagon. A test for the residual beta-cell function in diabetes mellitus.
    Faber OK; Binder C
    Diabetes; 1977 Jul; 26(7):605-10. PubMed ID: 326604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between residual insulin secretion and metabolic stability in type 1 (insulin dependent) diabetes.
    Lutterman JA; Benraad TJ; van 't Laar A
    Diabetologia; 1981 Aug; 21(2):99-102. PubMed ID: 7021291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoreactive gastric inhibitory polypeptide response to a meal during the first eighteen months after diagnosis of type 1 (insulin dependent) diabetes mellitus.
    Krarup T; Madsbad S; Moody AJ
    J Clin Endocrinol Metab; 1985 Jan; 60(1):120-5. PubMed ID: 3880559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic effect of tolbutamide in non-insulin dependent diabetes mellitus (NIDDM). Relation to beta-cell function.
    Damsgaard EM; Faber O; Frøland A; Iversen S
    Acta Endocrinol (Copenh); 1982 Jul; 100(3):416-20. PubMed ID: 7051723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glyburide enhances the responsiveness of the beta-cell to glucose but does not correct the abnormal patterns of insulin secretion in noninsulin-dependent diabetes mellitus.
    Shapiro ET; Van Cauter E; Tillil H; Given BD; Hirsch L; Beebe C; Rubenstein AH; Polonsky KS
    J Clin Endocrinol Metab; 1989 Sep; 69(3):571-6. PubMed ID: 2503533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-cell function and diabetic control in insulin dependent diabetes melletus.
    Faber OK
    Acta Endocrinol Suppl (Copenh); 1985; 272():73-7. PubMed ID: 3914807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of strict blood glucose control on residual B-cell function in insulin-dependent diabetics.
    Madsbad S; Krarup T; Reguer L; Faber OK; Binder C
    Diabetologia; 1981 May; 20(5):530-4. PubMed ID: 7026327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-cell responses in the offspring of non-insulin dependent diabetics after a test meal.
    Lovegrove JA; Pinder CJ; Jones J; Hampton SM
    Biochem Soc Trans; 1993 May; 21(2):122S. PubMed ID: 8359378
    [No Abstract]   [Full Text] [Related]  

  • 10. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.
    Vilsbøll T; Krarup T; Sonne J; Madsbad S; Vølund A; Juul AG; Holst JJ
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2706-13. PubMed ID: 12788877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of insulin absorption, subcutaneous blood flow, and residual beta-cell function in insulin therapy.
    Lauritzen T; Binder C; Faber OK
    Acta Paediatr Scand Suppl; 1980; 283():81-5. PubMed ID: 7010905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Residual pancreatic function in insulin dependent diabetics.
    Glatthaar C; Beaven DW; Donald RA; Smith JR; Espiner EA
    Aust N Z J Med; 1982 Feb; 12(1):43-7. PubMed ID: 7044357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Beta cell function in insulin-treated diabetes mellitus determined by C-peptide measurement].
    Faber OK
    Ugeskr Laeger; 1980 Jan; 142(4):215-21. PubMed ID: 6986696
    [No Abstract]   [Full Text] [Related]  

  • 14. [Assay of C-peptide in diabetes in children and adolescents].
    Jos J; Kestenbaum S
    Ann Med Interne (Paris); 1984; 135(6):416-9. PubMed ID: 6391322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of GLP-1 effects on beta-cell function after meal ingestion in humans.
    Ahrén B; Holst JJ; Mari A
    Diabetes Care; 2003 Oct; 26(10):2860-4. PubMed ID: 14514592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of continuous subcutaneous insulin infusion on endogenous insulin secretion in type I diabetes.
    Pietri A; Alford M; Raskin P
    Diabetes Care; 1982; 5(3):330-3. PubMed ID: 6756842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B-cell function and blood glucose control in insulin dependent diabetics within the first month of insulin treatment.
    Faber OK; Binder C
    Diabetologia; 1977 May; 13(3):263-8. PubMed ID: 873093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired first-phase insulin response predicts postprandial blood glucose increment in patients with recently diagnosed type 2 diabetes.
    Gredal C; Rosenfalck AM; Dejgaard A; Hilsted J
    Scand J Clin Lab Invest; 2007; 67(3):327-36. PubMed ID: 17454847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-peptide response to arginine infusion in insulin requiring diabetics.
    Fujii S; Tanaka S; Akai T; Ueda N; Nakatani K; Seki J; Wada M
    Osaka City Med J; 1978; 24(1):25-32. PubMed ID: 377185
    [No Abstract]   [Full Text] [Related]  

  • 20. Meal and oral glucose tests for assessment of beta -cell function: modeling analysis in normal subjects.
    Mari A; Schmitz O; Gastaldelli A; Oestergaard T; Nyholm B; Ferrannini E
    Am J Physiol Endocrinol Metab; 2002 Dec; 283(6):E1159-66. PubMed ID: 12388151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.